Medical Rehabilitation Research, Franciscan Children's Hospital, Brighton, Massachusetts, USA.
Department of Physical Therapy and Occupational Therapy, Boston Children's Hospital, Boston, Massachusetts, USA.
Phys Occup Ther Pediatr. 2021;41(4):410-428. doi: 10.1080/01942638.2020.1862384. Epub 2020 Dec 28.
To systematically examine the efficacy of lower extremity cycling interventions for youth with intellectual disability (ID).
Seven databases were searched from March 2000 to October 2019 for English-language articles on cycling interventions for youth with ID. The American Academy of Cerebral Palsy and Developmental Medicine guidelines were used for assigning levels of evidence and grading study quality.
Eight articles met inclusion criteria. Children and young adults, 7-26 years (n = 229), with diagnoses of Down syndrome, autism spectrum disorder, or unspecified ID participated in the studies. Moderate evidence (one level II single subject design study) suggests that a specific cycling intervention can improve two-wheeled cycling skills in youth with ID. Weak evidence (level II group studies) supports stationary cycling for short-term improvements in cognitive skills and two-wheeled riding intervention for increasing physical activity one-year after intervention.
Moderate to weak evidence exists to support two-wheeled cycling instructional programs or stationary cycling interventions for children and young adults with intellectual disabilities. Therapists can use this information when discussing cycling interventions for individuals with ID. Further research is needed to inform therapists in clinical decision-making related to dosing cycling interventions.
系统评估下肢循环干预对智力残疾(ID)青少年的疗效。
从 2000 年 3 月至 2019 年 10 月,检索了 7 个数据库,以获取有关 ID 青少年循环干预的英文文章。美国脑瘫与发育医学学院的指南用于确定证据水平和研究质量分级。
8 篇文章符合纳入标准。这些研究的参与者为患有唐氏综合征、自闭症谱系障碍或未明确 ID 的 7-26 岁儿童和青少年(n=229)。中等证据(一项二级单病例设计研究)表明,特定的循环干预可以改善 ID 青少年的两轮骑行技能。弱证据(二级群体研究)支持短期认知技能的固定循环,以及两轮骑行干预可在干预一年后增加身体活动。
存在中等至弱的证据支持两轮骑行教学计划或固定循环干预,适用于智力残疾儿童和青少年。治疗师在讨论 ID 个体的循环干预时可以使用这些信息。需要进一步的研究为治疗师在与循环干预剂量相关的临床决策中提供信息。